Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection

Food Additives and Contaminants - Part A

Volumn 29, Issue 2, 2012, Pages 161-171

  Rebiere, H ^a   Guinot, P ^a   Civade, C ^a   Bonnet, P A ^a   Nicolas, A ^a  

^a AFSSAPS   (France)

Author keywords

Adulterants; Dietary supplement; Screening; Sibutramine; Slimming preparation; Ultrahigh pressure liquid chromatography; Weight loss

Indexed keywords

COLUMN CHROMATOGRAPHY; COMMERCE; DIETARY SUPPLEMENTS; FOOD ADDITIVES; HAZARDS; LIQUIDS; NUTRITION; ORGANIC SOLVENTS; SCREENING; ULTRAVIOLET SPECTROSCOPY; VITAMINS;

ADULTERANTS; SIBUTRAMINE; SLIMMING PREPARATIONS; ULTRA-HIGH-PRESSURE LIQUID CHROMATOGRAPHY; WEIGHT LOSS;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

2,4 DINITROPHENOL; ACETONITRILE; ALTIZIDE; AMFEPRAMONE; AMPHETAMINE; BERGENIN; CAFFEINE; CLENBUTEROL; EPHEDRINE; FENFLURAMINE; FUROSEMIDE; HERBACEOUS AGENT; LEVOTHYROXINE; LIOTHYRONINE; METFORMIN; NICOTINAMIDE; OXEDRINE; PHENFORMIN; PHENOBARBITAL; PHENOLPHTHALEIN; PHENTERMINE; PHENYLALANINE; PHENYTOIN; PHOSPHATE BUFFERED SALINE; PSEUDOEPHEDRINE; RIMONABANT; SIBUTRAMINE; TRIAMTERENE; UNINDEXED DRUG; YOHIMBINE;

ANALYTIC METHOD; ARTICLE; DANGEROUS GOODS; DIET SUPPLEMENTATION; DIODE; DRUG FORMULATION; DRUG MARKETING; HEALTH HAZARD; INTERNET; PRIORITY JOURNAL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; WEIGHT REDUCTION;

EID: 84857420004     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/19440049.2011.638676     Document Type: Article

References (20)

1. AFSSAPS press release. 2003. [cited 2011 August 22]. Available from: http://www.afssaps.fr/Infos-de-securite/Communiques-Points-presse/EPHEDRA-MA-HUANGet-EPHEDRINE-decision-du-8-octobre-2003
2. AFSSAPS press release. 2008. Mise en garde sur les gélules " Best life ". [cited 2011 August 22]. Available from: http://www.afssaps.fr/Infos-de-securite/Communiques-de-presse/Mise-en-garde-sur-les-gelules-Best-life
3. Andrews KW, Schweitzer A, Zhao C, Holden JM, Roseland JM, Brandt M, Dwyer JT, Picciano MF, Saldanha LG, Fisher KD, et al. 2007. The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. Anal Bioanal Chem. 389:231-239.
4. Badoud F, Grata E, Perrenoud L, Avois L, Saugy M, Rudaz S, Veuthey JL. 2009. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatographyquadrupole time-of-flight mass spectrometry - I. Screening analysis. J Chromatogr A. 1216:4423-4433.
5. Biesemeier CK, Cummings SM. 2008. Ethics opinion: weight loss products and medications. J Am Diet Assoc. 108:2109-2113.
6. Bogusz MJ, Hassan H, Al-Enazi E, Ibrahim Z, Al-Tufail M. 2006. Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies. J Pharm Biomed Anal. 41:554-564.
7. Cianchino V, Acosta G, Ortega C, Martinez LD, Gomez MR. 2008. Analysis of potential adulteration in herbal medicines and dietary supplements for the weight control by capillary electrophoresis. Food Chem. 108:1075-1081.
8. De Carvalho LM, Martini M, Moreira APL, De Lima APS, Correia D, Falcao T, Garcia SC, De Bairros AV, Do Nascimento PS, Bohrer D. 2011. Presence of synthetic pharmaceuticals and adulterants in slimming phytotherapeutic formulations and their analytical determination. Forensic Sci Int. 204:6-12.
9. [EMA] European Medicines Agency. 1997. Position paper on the genotoxic and carcinogenic potential of phenolphthalein. [cited 2011 August 22]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Position_statement/2009/09/WC500003148.pdf
10. [EMA] European Medicines Agency press release. 2010. European Medicines Agency recommends suspension of marketing authorization for sibutramine. [cited 2011 August 22]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/01/ WC500069995.pdf
11. [EMA] European Medicines Agency. 2009. Acomplia - Withdrawal of the marketing authorization in the European Union. [cited 2011 August 22]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2009/11/WC500012189.pdf
12. European Directorate for the Quality of Medicines and Healthcare. European Pharmacopoeia. 7th ed. 2011.
13. FDA news release. 2009. FDA uncovers additional tainted weight loss products. [cited 2011 August 22]. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ ucm149547.htm
14. FDA warning. 2010. Counterfeit ALLI. [cited 2011 August 22]. Available from: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm198557.htm
15. Health Canada. 2010. It's your health: caffeine. [cited 2011 August 22]. Available from: http://www.hc-sc.gc.ca/hl-vs/alt_formats/pdf/iyh-vsv/food-aliment/caffeine-eng.pdf
16. [ICH] International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Q2(R1). 2005. Validation of analytical procedures: text and methodology.
17. Jung J, Hermanns-Clausen M, Weinmann W. 2006. Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int. 161:221-222.
18. Kerrigan S, Lindsey T. 2005. Fatal caffeine overdose: two case report. Forensic Sci Int. 1153:67-69.
19. Klose Nielsen MK, Johansen SS, Weihe Dalsgaard P, Linnet K. 2010. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci Int. 196:85-92.
20. Murray GJ, Danaceau JP. 2009. Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLCMS/ MS and UPLC-MS/MS. J Chromatogr B. 877: 3857-3864.